ArticleBMC women's health2025
Sexual dysfunction in women with breast cancer: a forgotten aspect among survivors.
Article in BMC women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Sexual function and activity in young adults with a primary brain tumor-A population-based longitudinal study.Neuro-oncology practice · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionBreast cancer strongly affects sexual desires physical and sexual attractiveness. This study was conducted to assess sexual function and related factors among women with breast cancer. MATERIALS AND
methodsThis study was performed on 149 women with breast cancer diagnosed by an oncologist, and the demographic and clinical data were also recorded. The Female Sexual Function Index (FSFI) was used to assess sexual function in women.
resultsThe mean score of sexual function in patients was 16.44 ± 8.85. Among participants, 137 (91.9%) had sexual dysfunction. The most frequent sexual disorder was related to dissatisfaction (75.8%) and arousal problems (72.5%). All disorders of sexual functions were significantly higher among patients older than 51 years, with pre-high school education level, menopausal status, marriage duration 28.40 ± 9.46years, number of children ≥ 3, and duration of breast cancer more than seven months (p < 0.05). The frequency of all sexual disorders, except for sexual function, was significantly higher in patients diagnosed with stage III breast cancer (p < 0.05). The complications in vaginal lubrication, and orgasm was significantly higher in those who underwent radiation therapy (p < 0.05). The results of this logistic regression analysis indicate that age and the duration of breast cancer are significantly associated with the likelihood of sexual dysfunction in the women (p < 0.05).
conclusionThis study reveals a high prevalence of sexual dysfunction among women with breast cancer, with a notably low mean sexual function score. Key factors contributing to these challenges include age, education level, menopausal status, and the duration of both breast cancer and marriage.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.